Vipul Organics Limited, a BSE-listed specialty chemicals company operating in the pigments and dyes segment, has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported strong year-on-year growth across revenue, profit before tax (PBT), profit after tax (PAT) and earnings per share (EPS) on a consolidated basis.
For Q1 FY2026-27, Vipul Organics recorded consolidated total revenue of Rs. 5,217.52 lakh, registering a 38.44% increase compared with Rs. 3,768.81 lakh reported in Q1 FY2025-26.
Consolidated PBT stood at Rs. 344.47 lakh, up 113% year-on-year from Rs. 161.72 lakh in the corresponding quarter last year. Consolidated PAT increased 99.75% to Rs. 252.46 lakh, compared with Rs. 126.39 lakh in Q1 FY2025-26.
The company’s consolidated EPS rose 54.65% year-on-year to Rs. 1.33, compared with Rs. 0.86 in the same quarter of the previous financial year.
Sequential Performance Remains Strong
On a quarter-on-quarter basis, Vipul Organics delivered continued improvement in profitability despite a marginal decline in revenue.
Consolidated revenue for Q1 FY2026-27 was Rs. 5,217.52 lakh, compared with Rs. 5,262.37 lakh in Q4 FY2025-26, representing a decline of 0.85%.
Consolidated PBT increased 14.53% QoQ to Rs. 344.47 lakh, compared with Rs. 300.76 lakh in the previous quarter. PAT grew 27.93% QoQ to Rs. 252.46 lakh, against Rs. 197.34 lakh in Q4 FY2025-26.
Consolidated EPS also improved by 20.9% QoQ, rising to Rs. 1.33 from Rs. 1.10.
Cost Optimisation and Diversification Support Growth
Commenting on the results, Mr. Vipul P. Shah, Managing Director, Vipul Organics Limited, said, “Our Q1 FY 2026-27 results reflect the continued strength of our core businesses and steady progress on our diversification into new segments. Cost optimization initiatives are beginning to translate into margin expansion. With our current capex cycle now complete, Vipul Organics is well positioned for a sustained cycle of growth. Our membrane division remains on track and will add a new, visible revenue stream for the Company going forward. We are also finalizing an internal multi-decadal roadmap, Vision 2045, which we will share with shareholders in due course.”
The company’s Q1 performance reflects the continued momentum in its core operations, while its diversification initiatives are expected to contribute to future growth. The completion of the current capex cycle is also expected to support the company’s focus on operational efficiency and margin improvement.
Vipul Organics said its membrane division remains on track, with the business expected to create an additional revenue stream for the company. The company is also working on its long-term Vision 2045 roadmap, which is expected to outline its strategic direction for the coming decades.
With revenue growth, stronger profitability and improving sequential performance, Vipul Organics enters FY2026-27 with a focus on strengthening its core specialty chemicals businesses while expanding into new growth opportunities.
